Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinoma

doi:10.3748/wjg.v28.i2.176

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6370)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

390

WORD

158

HTML

3696

Figures (1-3)

245

Tables (1-2)

322

Sum=4811

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

238

Download

366

Sum=604

Publishing Process of This Article

Item

Count

Browse

338

Download

617

Sum=955

Jan 14, 2022 (publication date) through May 1, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jan 14, 2022; 28(2): 176-187
Published online Jan 14, 2022. doi: 10.3748/wjg.v28.i2.176

Table 2 Nanotheranostic development againts hepatocellular carcinoma

Applications	Principle	Ref.
Diagnostic and therapeutic	Conventional SELEX	[87]
	CE-SELEX	[88]
	Magnetic nanoparticle-aptamer	[92]
Enhancing therapeutic	Inducing tumor regression using siRNA-nanoparticle construction	[100]
	Enhancing the anticancer efficacy using siRNA-nanoparticle construction	[101]
	Enhancing chemotherapy using microRNA 375-nanoparticle construction	[102]
	Synergistic antitumor effect of microRNA 375-nanoparticle construction	[103]
Diagnostic and guided-imaging	‘Activatable’ aptamer-based fluorescence probe	[104]
	Streptavidin-fluorescent silica nanoparticles combination	[105]
	Aptamer- based electrochemical biosensors	[106]
Gene editing	Next-generation CRISPR/Cas technology	[107]

HCC: Hepatocellular carcinoma; SELEX: Systematic Evolution of Ligands by Exponential Enrichment.

Citation: Ladju RB, Ulhaq ZS, Soraya GV. Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinoma. World J Gastroenterol 2022; 28(2): 176-187
URL: https://www.wjgnet.com/1007-9327/full/v28/i2/176.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i2.176